Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

PREventing CVD by predicting, understanding and mitigating sex-specific risks

Objectif

PRE-CVD envisions a future where cardiovascular disease (CVD) prevention is tailored to biological sex, gender, and life-course dynamics, enabling earlier detection, targeted intervention, and more equitable outcomes across Europe. PRE-CVD will deliver a scalable European framework integrating data, mechanistic insight, risk prediction, and real-world implementation to transform CVD prevention.

Despite major advances, current prevention relies on static, sex-neutral risk models that fail to capture life-course dynamics, hormone-sensitive transitions, and gender-related determinants. This leads to under-detection of high-risk women, fragmented care pathways, and persistent inequalities. PRE-CVD addresses these gaps by connecting discovery to implementation through a coherent translational workflow.

Focusing on CVD as the leading cause of mortality in Europe, particularly among women, PRE-CVD integrates large-scale electronic health records, cohort data, and multi-omics analyses to identify sex- and gender-specific risk trajectories, molecular mechanisms, and causal determinants across key life stages, including pregnancy, postpartum, and menopause. PRE-CVD delivers six key innovations: 1) a harmonised European data framework; 2) life-course modelling of sex- and gender-differential risk; 3) identification of causal determinants and molecular mechanisms; 4) development of validated sex- and gender-informed risk prediction models using clinical and AI approaches; 5) a co-designed Community Health Worker-led preventative intervention targeting high-risk women; and 6) evaluation of cost-effectiveness, scalability and equity impacts.

By embedding co-design, multi-country validation, and real-world pilot implementation, PRE-CVD bridges the gap between discovery and healthcare delivery. The consortium brings together leading experts to deliver a scalable solution for equitable cardiovascular prevention across Europe.

Champ scientifique (EuroSciVoc)

Mots‑clés

Programme(s)

Thème(s)

Régime de financement

HORIZON-RIA - HORIZON Research and Innovation Actions

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) HORIZON-HLTH-2026-01

Voir tous les projets financés au titre de cet appel

Coordinateur

FONDAZIONE HUMAN TECHNOPOLE
Contribution nette de l'UE
€ 1 678 890,00
Adresse
VIALE LEVI MONTALCINI RITA 1
20157 Milano
Italie
Région
Nord-Ovest Lombardia Milano
Type d’activité
Research Organisations
Liens
Coût total
Aucune donnée

Participants (12)